Multiplex Assays Market

Global Multiplex Assays Market Size (2024 to 2032)

The size of the global multiplex assays market was worth USD 3.53 billion in 2023. The global market is anticipated to grow at a CAGR of 7.15% from 2024 to 2032 and be worth USD 6.57 billion by 2032 from USD 3.78 billion in 2024. 

MARKET SCENARIO

Multiplex assays are used in research to measure multiple analytes in a single run simultaneously. It differs from the procedures that measure only one analysis at a time. For example, they are extensively used in experiments involving functional genomics. These experiments attempted to detect or assay the state of all biomolecules of a given class (e.g., mRNAs, proteins) in a biological sample to determine the effect of an experimental treatment or the impact of a DNA mutation over all of the biomolecules or pathways in the sample.

MARKET DRIVERS

The growing number of chronic illnesses, particularly cancer, where multiplex assays are widely employed, is one of the key factors driving the growth of the multiple assays market.

Due to the increased incidence of chronic diseases, the growing acceptance of personalized treatment, and the numerous advantages of multiplex assays over traditional assays, the market for multiplex assays is expected to develop rapidly. Other significant factors predicted to promote the growth of the global multiplex assays market are the numerous benefits of multiplex assays and fast advancements in nanotechnology. In addition, the market is also being driven by the usage of multiplex tests for diagnosing cancer, the benefits of multiplex assays over singleplex tests, immune system disorders, bone marrow diseases, and other infectious diseases, as well as technical advances in multiplex assay techniques.

More research activities in the pharmaceutical and biotechnological sectors, increased government funding, and a rising focus on improving the efficiency of experiments are further expected to propel the worldwide market forward. The growing recognition of the multifactorial character of illnesses and pathological situations such as cancer and Alzheimer's disease has necessitated the development of a method for measuring several analyzers in a single sample that is both cost-effective and time-saving. This factor drives the global market for multiplex tests. In the next few years, new growth opportunities will likely emerge from developing very dense nanoarray technology and attempting to deliver more improved and cost-effective solutions. Companion diagnostics are fast-growing in terms of number and use in disease areas and have quickly become an important element of personalized treatment. Companion diagnostics are expected to develop rapidly in the near future, based on the present product pipeline. This increase in companion diagnostics is likely to impact the development of the global multiplex assays market substantially.

MARKET RESTRAINTS

The high procurement prices and usage of multiplex assays are key major obstacles to the global multiplex assays market's growth. Furthermore, the global multiplex assays market will likely be hampered by strict government requirements for multiplex assay approval throughout the forecast period. The rising demand for healthcare systems to deliver services at a reasonable cost is expected to restrict the expansion of the Multiplex Assays Market. In addition, the Multiplex assay market is believed to be hampered by the complexity of clinical trial methods.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global Multiplex Assays Market Analysis By Product

Based on the product, the consumables sub-segment is expected to account for the largest share of the product segment due to increased demand for consumables.

Global Multiplex Assays Market Analysis By Type

The Protein-based assays segment is further categorized into planar protein assays and bead-based protein assays based on type. The protein-based assays segment is anticipated to witness the fastest growth in this segment of the multiplex assays market due to adopting these assays for research purposes.

Global Multiplex Assays Market Analysis By Application

The research & development segment is projected to account for the largest share of the multiplex assays market based on application. Factors such as convenience in performing the assays and quicker results offered by multiplex assays are aiding the growth of this segment.        

Global Multiplex Assays Market Analysis By Technology

The multiplex arrays segment is projected to hold the largest share of the multiplex assays market based on technology. Due to its benefits over traditional assays, the need for effective analytical platforms in research to reduce operational costs, and the adoption of companion diagnostics for increasing the safety and efficacy of therapy by multiplex assays are driving the growth of this segment.         

Global Multiplex Assays Market Analysis By End-User

Based on End User, the pharmaceutical and biotechnology companies segment is projected to account for the largest share due to the increase in the adoption of multiplex assays in this segment.

REGIONAL ANALYSIS

Geographically, North America accounts for the largest share of the global multiplex assays market in 2023.

The rise in the number of immunoassays tests performed and the prevalence of Alzheimer's patients drive the North American market. The U.S. is forecasted to rule the North American multiplex assay market due to the government's initiatives in improving precision medicine in advance, with strategic partners among the critical players in contesting for multiplex assay development. Moreover, the increasing per capita income of the United States is boosting the market. The rise in the geriatric population and many market players lead the US to the top in the North America Multiplex Assays Market. The Canadian market is predominantly growing due to the rise in R&D investments and the increasing number of cancer cases.

Europe accounts for the second-largest share in the global multiplex assays market during the forecast period. The increase in the geriatric population and chronic diseases are driving the European Multiplex Assays Market. Germany, France, and the U.K. are the primary European market contributors. The increase in clinical trials and the rise in investments in R&D in Germany are propelling the market. Moreover, government initiatives and healthcare expenditures are boosting the European Multiplex Assays Market.

Asia-Pacific is expected to witness the highest growth rate in the coming years. The risen prevalence of Alzheimer's patients and increasing patient population are driving the market. The countries like India and China are the most significant market contributors. Moreover, many pharmaceutical companies in India and China and a substantial rise in investments in research & development are propelling the Asia Pacific Multiplex Assays Market.

KEY MARKET PARTICIPANTS

Some of the notable companies leading the global multiplex assays market profiled in this report are Luminex Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Abcam Plc, Becton, Dickinson and Company, Luminex Corporation, Meso Scale Diagnostics, Randox Laboratories Ltd and Seegene Inc.

RECENT MARKET DEVELOPMENTS

• In February 2021, Thermo Fisher Scientific Inc., a provisioner of scientific instrumentation, reagents & consumables, and software & services to healthcare, life science, and other laboratories, acquired a privately held point-of-care molecular diagnostic company, Mesa Biotech, Inc.
• In September 2020, Biomedical Advanced Research and Development Authority (BARDA) partnered with Luminex Corporation, one of the key players in the Global Multiplex Assays Market, to develop a cost-effective, high throughput test that assesses the level of neutralizing antibodies in plasma.

DETAILED SEGMENTATION OF THE GLOBAL MULTIPLEX ASSAYS MARKET INCLUDED IN THIS REPORT

This market research report on the global multiplex assays market has been segmented and sub-segmented based on the product, type, application, technology, end-user, and region.

By Product

• Consumables
• Instruments
• Accessories
• Software and Services

By Type

• Nucleic Acid-Based Multiplex Assays          
  • Planar Nucleic Acid Assays
  • Bead-Based Nucleic Acid Assays
• Protein-Based Multiplex Assays   
  • Planar Protein Assays
  • Bead-Based Protein Assays

By Application

• Research & Development               
  • Drug Development
  • Biomarker Discovery and Validation
  • Infectious Diseases
  • Cancer
  • Cardiac Diseases
  • Autoimmune Diseases
  • Alzheimer’s Disease
  • Allergies
• Companion Diagnostics     
• Other Applications

By Technology

• Multiplex PCR
• Multiplex Arrays   
  • Multiplex Planar Arrays
  • Multiplex Bead-Based Array
• Other Technologies

By End-User

• Pharmaceutical & Biotechnology Companies          
• Academic & Research Institutes   
• Clinical Laboratories           
• Hospitals  
• Other End Users

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa